Multicenter Phase II Study of Mogamulizumab (KW-0761), a...

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Ogura, M., Ishida, T., Hatake, K., Taniwaki, M., Ando, K., Tobinai, K., Fujimoto, K., Yamamoto, K., Miyamoto, T., Uike, N., Tanimoto, M., Tsukasaki, K., Ishizawa, K., Suzumiya, J., Inagaki, H., Tamura
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2013.52.0924
Date:
April, 2014
File:
PDF, 139 KB
english, 2014
Conversion to is in progress
Conversion to is failed